OneMedNet Corporation (ONMD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
OneMedNet Corporation (ONMD) trades at $0.72 with AI Score 19/100 (Grade F). OneMedNet Corporation offers clinical imaging solutions through its iRWD platform, leveraging AI for data de-identification and curation. Market cap: $41.00M, Sector: Healthcare.
Price live · AI analysis from May 9, 2026Analyst Coverage for ONMD: ONMD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ONMD against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ONMD: 1/1 perspectives are bearish.
How is this calculated? →OneMedNet Corporation (ONMD) Healthcare & Pipeline Overview
OneMedNet Corporation provides clinical imaging solutions, utilizing its iRWD platform to apply AI in de-identifying and curating imaging data. Serving medical and academic research institutions, the company facilitates advancements in medical research, discovery, and diagnostics within the life sciences sector, despite current negative profitability margins.
What Is the Investment Thesis for ONMD?
OneMedNet Corporation operates in the growing healthcare information services sector, providing AI-driven clinical imaging solutions. The iRWD platform's ability to de-identify and curate imaging data offers a valuable service to medical and academic research institutions. However, the company's negative profit margin of -206.1% and gross margin of -37.0% raise concerns about its financial sustainability. The company's small market capitalization of $41.00M also indicates a high-risk investment. Future growth hinges on expanding its customer base and achieving profitability through efficient operations and strategic partnerships. The company's beta of 1.17 suggests a slightly higher volatility compared to the market.
Based on FMP financials and quantitative analysis
ONMD Key Highlights
- Market capitalization of $41.00M, indicating a micro-cap company.
- Negative profit margin of -206.1%, reflecting significant losses.
- Negative gross margin of -37.0%, suggesting challenges in cost management.
- iRWD platform utilizes AI to de-identify and curate imaging data.
- Beta of 1.17, indicating slightly higher volatility compared to the market.
Who Are ONMD's Competitors?
ONMD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.72 | +3.54% | $8.46M | 54 |
| CERN Cerner Corporation | $94.92 | +0.00% | 54 | |
| CRVW CareView Communications, Inc. | $0.05 | -8.31% | $30.65M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ONMD's Key Strengths?
- Proprietary iRWD platform with AI capabilities
- Expertise in data de-identification and curation
- Focus on serving medical and academic research institutions
- Potential to accelerate medical research and diagnostics
What Are ONMD's Weaknesses?
- Negative profit margin and gross margin
- Small market capitalization
- Limited financial resources
- Dependence on a small team of employees
What Could Drive ONMD Stock Higher?
- Expansion of partnerships with medical research institutions to drive iRWD platform adoption.
- Development and integration of advanced AI algorithms into the iRWD platform for enhanced image analysis.
- Potential regulatory approvals for new data analytics services, expanding market reach.
- Focus on securing additional funding to support growth initiatives and improve financial stability.
What Are the Key Risks for ONMD?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Negative profit margin and gross margin pose a threat to financial sustainability.
- Competition from larger, more established players in the healthcare IT space.
- Regulatory changes and data security concerns could impact the iRWD platform's compliance.
- Economic downturn and reduced research funding could limit growth opportunities.
- Technological advancements could render the iRWD platform obsolete.
What Are the Growth Opportunities for ONMD?
- Expansion of iRWD Platform Capabilities: OneMedNet can enhance its iRWD platform by integrating advanced AI algorithms for image analysis and diagnostics. This would attract a broader range of research institutions and pharmaceutical companies seeking comprehensive imaging solutions. The market for AI in medical imaging is projected to reach $3.5 billion by 2028, offering a significant growth opportunity for OneMedNet. Timeline: 1-2 years.
- Strategic Partnerships with Research Institutions: Collaborating with leading medical and academic research institutions can provide OneMedNet with access to valuable data and expertise. These partnerships can also serve as case studies to demonstrate the effectiveness of the iRWD platform, attracting new customers. The market for research collaborations in healthcare is estimated at $10 billion annually. Timeline: Ongoing.
- Geographic Expansion into New Markets: OneMedNet can expand its operations beyond the United States by targeting international markets with high demand for clinical imaging solutions. This would diversify its revenue streams and reduce its reliance on the domestic market. The global market for healthcare IT is projected to reach $390 billion by 2027. Timeline: 2-3 years.
- Development of New Data Analytics Services: OneMedNet can leverage its expertise in data de-identification and curation to develop new data analytics services for the healthcare industry. This could include providing customized data reports, predictive analytics, and data-driven insights to help healthcare providers improve patient outcomes. The market for healthcare analytics is projected to reach $75 billion by 2028. Timeline: 1-2 years.
- Focus on Regulatory Compliance and Data Security: As the healthcare industry becomes increasingly regulated, OneMedNet can differentiate itself by prioritizing regulatory compliance and data security. This would build trust with customers and attract organizations that require robust data protection measures. The market for healthcare cybersecurity is projected to reach $25 billion by 2027. Timeline: Ongoing.
What Opportunities Does ONMD Have?
- Expansion of iRWD platform capabilities
- Strategic partnerships with research institutions
- Geographic expansion into new markets
- Development of new data analytics services
What Threats Does ONMD Face?
- Competition from larger, more established players
- Regulatory changes and data security concerns
- Economic downturn and reduced research funding
- Technological advancements that could render iRWD obsolete
What Are ONMD's Competitive Advantages?
- Proprietary iRWD platform with AI-driven capabilities.
- Expertise in data de-identification and curation.
- Established relationships with medical and academic research institutions.
What Does ONMD Do?
OneMedNet Corporation, based in Eden Prairie, Minnesota, specializes in clinical imaging solutions. The company's core offering is iRWD, a platform that leverages artificial intelligence to securely de-identify, search, and curate imaging data. This technology is primarily aimed at supporting a network of medical and academic research institutions. By facilitating efficient data management and analysis, OneMedNet aims to accelerate progress in medical research, discovery, and diagnostics across various life science domains. The iRWD platform enables researchers to access and utilize imaging data more effectively, addressing a critical need in the healthcare industry. The company focuses on providing tools that enhance data utility while maintaining patient privacy, a crucial aspect of handling sensitive medical information. OneMedNet's solutions are designed to streamline the research process, allowing institutions to focus on innovation and development. The company currently manages its operations with a team of 22 employees. OneMedNet's business model centers around providing advanced data solutions to the medical research community, positioning itself as a key enabler of cutting-edge research and diagnostic advancements. While the company's history and founding details are not fully available, its current focus is clearly on leveraging AI to transform clinical imaging data management.
What Products and Services Does ONMD Offer?
- Provides clinical imaging solutions to healthcare organizations.
- Offers the iRWD platform for AI-driven data de-identification and curation.
- Serves medical and academic research institutions.
- Facilitates advancements in medical research and diagnostics.
- Enables efficient data management and analysis.
- Supports data utility while maintaining patient privacy.
- Streamlines the research process for healthcare institutions.
How Does ONMD Make Money?
- Provides subscription-based access to the iRWD platform.
- Offers customized data analytics services to healthcare providers.
- Generates revenue through strategic partnerships with research institutions.
What Industry Does ONMD Operate In?
OneMedNet Corporation operates within the healthcare information services industry, a sector experiencing growth driven by the increasing digitization of medical data and the demand for advanced analytics. The market for AI-driven healthcare solutions is expanding, with research institutions and pharmaceutical companies seeking efficient ways to manage and analyze clinical data. OneMedNet's iRWD platform addresses this need by providing tools for data de-identification and curation. However, the company faces competition from larger, more established players in the healthcare IT space, requiring it to demonstrate a clear competitive advantage to gain market share.
Who Are ONMD's Key Customers?
- Medical research institutions
- Academic research institutions
- Pharmaceutical companies
- Healthcare providers
ONMD Valuation & Market Position
With a $41.00M market cap, OneMedNet Corporation sits in the micro-cap segment of the market. Relative to its peer group, ONMD's quantitative score of 19/100 is below the peer average of 65/100.
ROE 90%Key Financial Metrics
Return on equity for OneMedNet Corporation stands at 90.5%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -18.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.27 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -8.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
OneMedNet Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ONMD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recientemente, la actividad de los insiders ha mostrado una tendencia de compra, lo que sugiere confianza en el futuro de la empresa.
- La comunidad ha estado hablando positivamente sobre la innovación de productos de OneMedNet, lo que indica un fuerte interés en su tecnología.
- Los recientes desarrollos en asociaciones estratégicas han generado un optimismo considerable entre los inversores.
- El aumento en la adopción de soluciones de salud digital ha impulsado el interés en empresas como OneMedNet, alineándose con tendencias de mercado favorables.
Bear Case
- A pesar del optimismo, algunos analistas han expresado preocupaciones sobre la competencia creciente en el sector de salud digital.
- La percepción del mercado ha sido cautelosa, con algunos comentarios negativos sobre la escalabilidad de sus soluciones.
- Recientes críticas en foros de inversión han señalado la necesidad de una mayor transparencia en sus operaciones.
- Algunos inversores están preocupados por la dependencia de la empresa en financiamiento externo para su crecimiento, lo que podría ser un riesgo en el futuro.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
ONMD Latest News
-
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga · Oct 6, 2025
ONMD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ONMD.
Price Targets
Wall Street price target analysis for ONMD.
ONMD MoonshotScore
What does this score mean?
The MoonshotScore rates ONMD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Aaron Green
CEO
Aaron Green serves as the CEO of OneMedNet Corporation, leading a team of 22 employees. Information regarding his detailed career history, educational background, and previous roles is not available. As CEO, he is responsible for the overall strategic direction and operational management of the company, focusing on the growth and development of the iRWD platform and expansion of the company's customer base.
Track Record: Specific achievements and milestones under Aaron Green's leadership are not available. His tenure involves navigating the company through a period of negative profitability and focusing on leveraging AI to enhance clinical imaging solutions. He is responsible for fostering partnerships with medical and academic research institutions to drive adoption of the iRWD platform.
ONMD Healthcare Stock FAQ
What does OneMedNet Corporation do?
OneMedNet Corporation is a healthcare information services company that provides clinical imaging solutions. Its primary product, the iRWD platform, utilizes artificial intelligence to de-identify, search, and curate imaging data for medical and academic research institutions. By enabling efficient data management and analysis, OneMedNet aims to accelerate progress in medical research, discovery, and diagnostics. The company focuses on providing tools that enhance data utility while maintaining patient privacy, positioning itself as a key enabler of cutting-edge research and diagnostic advancements.
What do analysts say about ONMD stock?
Analyst coverage of OneMedNet Corporation (ONMD) is currently limited due to its small market capitalization and financial performance. Key valuation metrics, such as price-to-earnings ratio, are not applicable due to the company's negative profitability. Growth considerations center on the successful adoption of the iRWD platform and the company's ability to achieve profitability through efficient operations and strategic partnerships. Investors should carefully consider the company's financial risks and competitive landscape before making investment decisions. There is no consensus rating available.
What are the main risks for ONMD?
OneMedNet Corporation faces several key risks. The company's negative profit and gross margins raise concerns about its financial sustainability. Competition from larger, more established players in the healthcare IT space poses a significant challenge. Regulatory changes and data security concerns could impact the iRWD platform's compliance and market acceptance. An economic downturn and reduced research funding could limit growth opportunities. Finally, technological advancements could render the iRWD platform obsolete, requiring continuous innovation and adaptation.
What are the key factors to evaluate for ONMD?
OneMedNet Corporation (ONMD) holds an AI score of 19/100 (low). Not financial advice.
How frequently does ONMD data refresh on this page?
ONMD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ONMD's recent stock price performance?
OneMedNet Corporation (ONMD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary iRWD platform with AI capabilities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ONMD overvalued or undervalued right now?
Valuing OneMedNet Corporation (ONMD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ONMD?
Before investing in OneMedNet Corporation (ONMD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- Analyst coverage is minimal, resulting in limited consensus information.
- Company information is based on available public sources and may not be comprehensive.